C Caselli
Overview
Explore the profile of C Caselli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuccitelli C, Valentini A, Caletti M, Caselli C, Mazzella N, Forlani G, et al.
J Endocrinol Invest
. 2017 Aug;
41(3):307-314.
PMID: 28803346
Background: Despite intensive training, a few individuals with Type 1 diabetes mellitus (T1DM) fail to reach the desired metabolic targets. Aim: To evaluate the association between disease-related emotional and cognitive...
2.
Vitale M, Masulli M, Cocozza S, Anichini R, Babini A, Boemi M, et al.
Nutr Metab Cardiovasc Dis
. 2016 May;
26(10):879-85.
PMID: 27212622
Background And Aims: Diabetic women have a more adverse plasma lipid profile than men. Sex differences in dietary habits may play a role, but are little investigated. The study evaluates...
3.
Turchetti G, Lorenzoni V, Bellelli S, Pierotti F, Rovai D, Caselli C, et al.
Value Health
. 2016 May;
17(7):A474.
PMID: 27201365
No abstract available.
4.
Cabiati M, Burchielli S, Matteucci M, Svezia B, Panchetti L, Caselli C, et al.
Peptides
. 2015 Jan;
64:67-73.
PMID: 25613228
Dipyridamole (DP) restores ischemic tissue blood flow stimulating angiogenesis in eNOS-dependent pathways. C-type natriuretic peptide (CNP) is expected to mimic the migration-stimulatory effect of NO via a cGMP-dependent mechanism. Aim...
5.
Cabiati M, Belcastro E, Caselli C, Prescimone T, DAmico A, Guzzardi M, et al.
Nutr Metab Cardiovasc Dis
. 2014 Jul;
24(11):1166-73.
PMID: 25012866
Background And Aims: The deregulation of neurohormonal systems, including the natriuretic peptide (NP) and endothelin (ET) systems, may increase the possibility of developing obesity-related risk. The aim of our paper...
6.
Caselli C, DAmico A, Cabiati M, Prescimone T, Del Ry S, Giannessi D
Pharmacol Res
. 2014 Mar;
82:9-20.
PMID: 24657240
Cardiovascular disease (CVD) is the leading cause of death worldwide and the prevalence of obesity and diabetes are increasing. In obesity, adipose tissue increases the secretion of bioactive mediators (adipokines)...
7.
Caselli C, DAmico A, Ragusa R, Caruso R, Prescimone T, Cabiati M, et al.
Mediators Inflamm
. 2014 Jan;
2013:498703.
PMID: 24385685
Background: Inflammation is a critical process contributing to heart failure (HF). We hypothesized that IL-33/ST2 pathway, a new mechanism regulated during cardiac stress, may be involved in the functional worsening...
8.
Del Ry S, Cabiati M, Bianchi V, Storti S, Caselli C, Prescimone T, et al.
Peptides
. 2013 Oct;
50:50-4.
PMID: 24120372
The high prevalence of obesity in children may increase the magnitude of lifetime risk of cardiovascular disease (CD). At present, explicit data for recommending biomarkers as routine pre-clinical markers of...
9.
Cabiati M, Sabatino L, Caruso R, Verde A, Caselli C, Prescimone T, et al.
Peptides
. 2013 Aug;
47:110-4.
PMID: 23911666
The aim of this study was to evaluate the transcriptomic profiling of C-type natriuretic peptide (CNP) and of its specific receptor, NPR-B in human leukocytes of heart failure (HF) patients...
10.
Del Ry S, Cabiati M, Martino A, Cavallini C, Caselli C, Aquaro G, et al.
Int J Cardiol
. 2013 Apr;
168(3):2426-34.
PMID: 23561919
Background: Vasculogenesis is a hallmark of myocardial restoration. Post-ischemic late remodeling is associated with pathology and function worsening. At the same time, neo-vasculogenesis helps function improving and requires the release...